Clough Capital Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-820
Closed -$260K 139
2024
Q3
$260K Hold
820
0.03% 127
2024
Q2
$306K Sell
820
-26,960
-97% -$9.1M 0.03% 113
2024
Q1
$9.63M Buy
+27,780
New +$10.5M 1.06% 39
2021
Q3
Sell
-59,150
Closed -$26.2M 129
2021
Q2
$26.2M Sell
59,150
-4,865
-8% -$2.13M 1.42% 25
2021
Q1
$26.8M Buy
+64,015
New +$25.6M 1.2% 25
2019
Q1
Sell
-28,308
Closed -$8.11M 148
2018
Q4
$8.11M Buy
+28,308
New +$8.97M 0.95% 37
2016
Q2
Sell
-49,140
Closed -$8.99M 208
2016
Q1
$8.99M Buy
49,140
+10,887
+28% +$1.89M 0.42% 75
2015
Q4
$6.83M Sell
38,253
-6,313
-14% -$1.11M 0.32% 93
2015
Q3
$7.98M Buy
44,566
+25,741
+137% +$4.76M 0.35% 76
2015
Q2
$3.6M Buy
+18,825
New +$3.49M 0.14% 122

Other funds holding HUM

Clough Capital Partners's HUM Position: Q4 2024 in Review

Clough Capital Partners sold out of Humana (HUM) in Q4 2024, closing a stake of 820 shares — an estimated $260K sold.

Clough Capital Partners first reported a position in HUM in Q2 2015 and held it in 10 quarters. The position peaked at $26.8M in Q1 2021. 877 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

  • Clough Capital Partners reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
  • Clough Capital Partners sold 820 Humana shares in Q4 2024, an estimated $260K.
  • Clough Capital Partners first reported a position in Humana in Q2 2015 and held it in 10 quarters.
  • Clough Capital Partners's Humana position peaked at $26.8M in Q1 2021.
  • 877 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Clough Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.